ArticlePLOS global public health2026
Health-system challenges, resilience strategies, and actionable priorities for non-communicable disease care in humanitarian crises: A scoping review.
Article in PLOS global public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Humanitarian crises disrupt the continuous care required for non-communicable diseases (NCDs), yet evidence on effective health-system responses remains fragmented. We conducted a scoping review, reported in accordance with PRISMA-ScR, to map health-system challenges, implemented and recommended strategies, resilience functions, and evidence gaps for cardiovascular diseases, diabetes, cancer, and chronic respiratory diseases in humanitarian settings. PubMed/MEDLINE, Scopus, Web of Science, relevant organizational websites, and reference lists were searched. English-language empirical studies, reviews, programme reports, guidelines, policy documents, and operational frameworks addressing continuity of NCD care during crises were eligible. Evidence was synthesized across nine operational domains and characterized according to patient or clinical outcomes, service or implementation outcomes, descriptive or recommendation-only evidence, and economic information. Thirty-seven sources published between 2013 and 2025 were included. Country-specific empirical evidence was concentrated in Asia and the Middle East. Service delivery had the strongest outcome-based evidence, whereas financing, coordination, governance, and transformative system reforms were supported mainly by descriptive or recommendation-based sources. No full comparative economic evaluation was identified. Reported challenges involved disrupted access and referral, failures of medicines and infrastructure, workforce and information constraints, and financial and social barriers. Implemented strategies included integrated primary care, mobile and telemedicine services, structured follow-up, medicine-continuity measures, electronic monitoring, and community and workforce interventions. Empirical evidence predominantly addressed absorptive and adaptive responses; transformative strategies were mainly proposed in guidance and policy documents and were rarely evaluated. Three cross-cutting priorities emerged from the synthesis: a minimum emergency NCD service and medicine package; continuity mechanisms for patients at highest risk from treatment interruption; and simplified, integrated NCD care within emergency and primary-care services. Future research should prospectively evaluate these priorities using standardized implementation, clinical, equity, and economic indicators and should involve affected communities and frontline practitioners in intervention design and assessment.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.